用碳酸封装纤维素因子以控制出血
Henry T Peng1, Tristan Bonnici1, Christian Kastrup2,3
1Defence Research and Development Canada, Toronto Research Centre, Toronto, ON M3K 2C9, Canada.
Military medicine
|September 23, 2025
概括
研究人员使用三种方法开发了纤维素原封装的碳酸 (CaCO3) 颗粒,以改善血静. 沉方法显示出最强的静血效应,而封装颗粒则表现出更强的自我推进,以控制出血.
科学领域:
- 生物材料科学 生物材料科学
- 止血剂 止血剂 止血剂
- 纳米技术 纳米技术
背景情况:
- 与战斗有关的出血是可预防死亡的主要原因.
- 现有的静血包裹使用碳酸 (CaCO3) 微粒和酸.
- 结合纤维激素可以增强静血效果.
研究的目的:
- 通过三种新的方法合成纤维素素封装的CaCO3颗粒.
- 为了评估这些颗粒的静血和自动推进性质.
- 为了比较不同制备技术的疗效.
主要方法:
- 通过水-油-水封装,沉和气体扩散合成纤维素-CaCO3颗粒.
- 具有特征的粒子形态,纤维素分布 (使用光素异硫酸标签),静血效应 (旋转血栓电平计) 和自我推进 (视频运动跟踪).
- 研究了不同碳酸盐来源和制备条件的影响.
主要成果:
- 沉和封装方法产生了球形,微米大小的颗粒;气体扩散产生了不规则的形状.
- 在所有方法中都证实了纤维素包装;沉颗粒显示出最强的静血效应.
- 所有含有纤维素素的颗粒都表现出自我推进;封装颗粒显示出更快的反应和更高的推进速度.
结论:
- 多种技术有效地产生纤维素素封装的CaCO3颗粒,具有静血和自动推进能力.
- 制备方法显著影响颗粒的特性和性能.
- 计划进一步优化配方,以增强血液控制特性.
更多相关视频
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
9.7K
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.3K
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:05Introduction to Hemostasis
13.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.4K
01:16Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
01:09Coagulation
9.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.7K
01:06Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K